|
HS Code |
360904 |
| Product Name | 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid |
| Cas Number | 62256-38-6 |
| Molecular Formula | C8H5BrN2O2 |
| Molecular Weight | 241.05 g/mol |
| Appearance | White to off-white powder |
| Melting Point | Over 300°C (dec.) |
| Solubility | Slightly soluble in water; soluble in DMSO and DMF |
| Purity | Typically >98% |
| Storage Conditions | Store at 2-8°C, protected from light |
| Smiles | C1=CC2=C(C(=C1)Br)NC(=N2)C(=O)O |
| Inchi | InChI=1S/C8H5BrN2O2/c9-5-1-2-6-7(3-5)11-8(10-6)4(12)13/h1-3H,(H,12,13)(H2,10,11) |
| Synonyms | 6-Bromo-benzimidazole-4-carboxylic acid |
As an accredited 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of work in synthesis teach a person about the weight that starting materials carry. Some compounds just make the journey smoother. 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid does exactly that for chemists working in medicinal or organic research. Instead of long reaction chains, you start from a platform already equipped with reactivity and versatility. By picking this compound, researchers cut out steps, minimize waste, and tackle projects that demand precision.
In the world of heterocyclic chemistry, benzimidazole rings rarely let you down. The twist here comes from the bromine at the 6-position and a carboxylic acid on the 4-carbon. That substitution opens doors not always available in unsubstituted cores. The extra electron density and polarity tweaks how reactions play out. Routine amide coupling, Suzuki reactions, or protecting group strategies all get a facelift. One fact stands out: the presence of bromine lends access to clear cross-coupling; chemists can attach aryl or alkyl chains easily, tailoring downstream molecules to their needs.
Many experienced teams run into bottlenecks with less functionalized benzimidazoles. A plain structure often means more protecting and deprotecting steps, strict control of reaction conditions, and labor spent recovering yield. Swap those out for this 6-bromo derivative, and you see fewer headaches. With the carboxylic acid exposed on the ring, you can imagine using standard peptide coupling or condensation to build libraries quickly. The amount of published work using this core for kinase inhibitors demonstrates its real-world value. Academic teams and industry scientists, chasing either targeted therapies or probe molecules, have published more than a dozen examples of selective inhibition built on this very skeleton.
Too many synthetic campaigns slow down because standard benzimidazoles lack the handles needed for modular reactions. I’ve watched promising projects held up by the wrong starting block — a reminder to never ignore functional groups. This compound’s structure lets teams pull off reactions that pure benzimidazole can’t match. The bromine acts as a point for palladium-catalyzed processes, and the carboxyl group brings a handle for further derivatization, especially important in bioconjugation.
Not every project needs this level of tweak, but for anyone pushing boundaries in medicinal chemistry, precision matters. Small changes near the benzimidazole nucleus transform biological properties, solubility, and metabolic fate. Medicinal chemists in particular keep an eye on halogenated cores; they’re not just about reactivity, but can also directly impact cell permeability and receptor binding. The 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid core gives researchers the flexibility to fine-tune pharmacokinetics—not a minor point if you’re working toward a clinical candidate or focused probe.
Handling this compound doesn’t call for exotic techniques. From experience, it comes off a white to off-white solid, generally stable under lab conditions when kept dry and away from direct sunlight. Dissolving it in common solvents such as DMSO, DMF, or even aqueous buffers takes little coaxing. Some teams prefer to dissolve it at slightly elevated temperatures for coupling reactions, but the substance behaves predictably.
Specifications vary, but research-grade material often shows purity above 98% by HPLC—enough for medicinal chemistry work and most process development campaigns. Particle size rarely presents a hurdle; most commercial samples arrive as fine powders, enabling straightforward scale-up or formulation work. The melting point typically hovers somewhere above 200°C, allowing it to withstand the demands of most synthetic protocols without decomposing before use.
Comparisons with other substituted benzimidazole acids show that the 6-bromo analog stands out in Suzuki–Miyaura couplings, Stille reactions, or direct amidation due to its reliable bromine leaving group. Those who have worked with chlorinated or unsubstituted versions know that bromine’s role as a leaving group vastly improves cross-coupling yields and selectivity. While iodo-analogs sometimes win on reactivity, their availability and stability lag behind, especially on scale. Chlorinated compounds prove less reactive and force users to crank up conditions to the detriment of sensitive functional groups.
As with most heteroaromatics, storage and solubility sometimes pop up as minor concerns. For longer projects, storing the bulk powder in an inert atmosphere helps maintain its integrity, but sealed vials under dry air usually suffice. Moisture doesn’t spell disaster, but best practice keeps things tightly capped to avoid caking or slow hydrolysis of the acid group. We’ve had samples open on the bench for weeks with no visible change, though for regulated work it pays to check purity over time.
Those unfamiliar with halogenated aromatic acids sometimes worry about unpleasant odors or safety issues. Fortunately, this compound steers clear of such pitfalls. Sensible laboratory hygiene—wearing gloves, working with local ventilation, and using goggles—addresses all foreseeable risks. Multiple suppliers provide both safety testing and purity checks using NMR and mass spectrometry, so the product matches label claims.
The real draw behind 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid lies in its ready adaptation to diverse synthetic protocols. Labs looking to build libraries for structure–activity studies, ligands for organometallic complexes, or tools for probing enzyme binding sites have found consistent results using this core. The literature reflects a steady stream of kinase inhibitor development, especially among those targeting ATP-binding domains or demonstrating selectivity for cancer cell lines.
One project I recall involved linking this acid to polyethylene glycol for conjugation with fluorophores—a strategy that delivered reliable performance in diagnostic assays. The chemistry felt seamless: robust carboxylic acid activation, clean amide couplings, and no tough purification antics. Compare that with memories of less functionalized benzimidazoles requiring multi-step modifications, and the savings in time and solvents become clear.
For teams working at small scale or scaling up, access to a brominated handle means less wasted material. In scaling campaigns, side reactions drop off, and the final products reflect straightforward purification profiles. Skilled synthetic chemists often prize time above all: this product delivers on that front, opening opportunities for iterative analog synthesis without the overhead of difficult reaction monitoring or unanticipated byproducts.
Benzimidazole cores occupy an important corner of medicinal chemistry because of their prevalence in natural products and potent pharmaceuticals. The 6-bromo-4-carboxylic acid variant plays into that strength, serving as a scaffold for further biological exploration. Research teams targeting diseases from oncology to infectious pathologies continue to survey ring-substituted benzimidazoles.
Unlike some halogenated systems, this compound balances functional group reactivity with relatively mild cytotoxicity profiles, expanding its uses in early-stage screening campaigns. Some university labs test these cores for anti-viral, anti-fungal, and anti-proliferative effects. The carboxylic acid, either left exposed or masked as an ester, adapts to both in vitro assays and in vivo studies. The bromine substitution also signals to computational chemists running docking studies that the molecule offers meaningful bioisosteric exchange, letting them tailor series for specific targets without wholesale redesign.
Medicinal chemistry isn’t just about finding hits; it’s the grind of optimization—solubility, metabolic half-life, binding affinity, and selectivity all pulling in different directions. Using a starting point such as this benzimidazole, project teams gain flexibility. Adjust the acid, modify the ring, or swap out the bromine for another substituent, and each change brings a measurable impact to ADME (absorption, distribution, metabolism, excretion) properties. This adaptability proves essential in patent landscaping, lead candidate selection, and the search for novel mechanisms.
Getting ahold of reliable material marks a difference between stalled experiments and breakthroughs. The reputation of 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid reflects not just commercial availability but decades of synthetic chemistry written in the journals. Unlike obscure or boutique intermediates, this benzimidazole analog appears routinely in methods published by both academic and industry groups. Teams new to this compound benefit from established protocols, peer-reviewed optimization tips, and a support network of experts who have shared real-world case studies.
Supplier choice influences experience, so many chemists stick with those who offer solid packaging, traceable quality control, and technical support. Repeat orders stay consistent, and unexpected impurities rarely crop up. For anyone on the fence about switching from older benzimidazole builds, published case studies often sway the decision: clean chromatography, high coupling yields, and straightforward post-reaction workups.
It pays to track the safety data and environmental impact, too. While halogenated aromatics sometimes trigger concerns, this compound generally receives manageable hazard labels, similar to other brominated building blocks. Waste disposal follows routine protocols for organic acids and halide-containing intermediates—no surprises for trained staff. Teams with an eye on sustainability or regulatory shifts find reassurance in the broad documentation and established precedents for handling, storage, and disposal.
Trends in fragment-based drug discovery, high-throughput screening, and precision diagnostics keep raising demand for flexible, reliable synthetic intermediates. Those of us who have watched research cycles adapt to new challenges see the appeal in ready-to-use benzimidazoles. This 6-bromo-4-carboxylic acid does not stall; it moves projects forward.
Emerging methods in bioconjugation, photoredox catalysis, and surface modification thrive on building blocks that combine stability with adaptability. Startups pushing targeted delivery vehicles or antibody-drug conjugates look for versatile handles—bromoaromatics such as this stand out. Researchers on limited budgets appreciate starting materials with track records: less troubleshooting, more progress, and better use of funding.
The compound’s presence in recent patents for kinase inhibitors, imaging agents, and specialty polymer modification stands as evidence. Whether the goal is to fine-tune molecular weight, tune hydrophilicity, or introduce new chemical space, the 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid structure fits. Instead of searching for exotic or unproven intermediates, research teams anchor their work in reliability.
After years working with aromatic synthons, I recommend documenting each batch of this compound upon receipt with your preferred quality checks: NMR, melting point, and TLC profiles keep standards high. Storage under desiccation means less risk of caking, and regular weighing tracks any subtle hydration over time. For large projects, planning ahead helps avoid last-minute supply crunches. Common mistakes—such as overlooking scale-up impurities or using non-anhydrous solvents—can be sidestepped with a few minutes’ attention up front.
From the first test reaction to campaign scale, most teams walk away surprised at the ease of coupling and post-reaction cleanup. Workups run with minimal solvent washes. HPLC or LC-MS confirmation proves straightforward without stubborn byproducts clogging detection windows. Comparison with less functionalized starting materials shows up in both yield and time saved—a lesson no researcher forgets once they have been through a few campaign cycles.
Online forums and professional networks frequently highlight the product’s consistency and the direct impact on productivity it brings to the bench. Chemists swapping stories about difficult couplings or low-yielding reactions regularly point to the benefits that come from starting with the right functional handles. For students entering the field or seasoned synthetic chemists under deadline pressure, tools that cut down extraneous steps mean more rapid results.
In undergraduate labs, I’ve seen this compound touch off curiosity about heterocycle chemistry. Its tangible differences from unsubstituted benzimidazole let new chemists witness the effect that minor ring changes have on reactivity, highlighting important lessons about electronic effects and functional group compatibility. These lessons carry well beyond the academic sphere, equipping future researchers with a sharper toolkit and a better appreciation for synthetic planning.
Nothing beats time saved and reliability proved across countless projects. In a landscape where funding cycles tighten and publication deadlines loom, proven intermediates earn their stripes. The role 6-Bromo-1H-Benzimidazole-4-Carboxylic Acid fills goes far beyond a single reaction or product—it acts as a launchpad for ideas, experiments, and innovation.
Having relied on it across different sectors and applications, I see where this compound makes the difference between days troubleshooting and days progressing. Whether assembling new pharmaceuticals, designing tools for biochemical research, or simply exploring the bounds of heterocyclic chemistry, this benzimidazole stands out in both reliability and adaptability. For the teams willing to learn from past campaigns and leverage modern chemistry’s best building blocks, it holds a well-earned place in the lab’s inventory and the chemist’s workflow.